(4-Imidazo[4,5-b]pyridin-3-yl-phenyl)-acetic acid → N-(5-tert-Butyl-2-(4-morpholin-4-ylmethyl-phenyl)-2H-pyrazol-3-yl)-2-(4-Imidazo[4,5-b]pyridine-3-yl-phenyl)-acetamide
Reaction equation
[N:1]1[C:9]2[C:4](=[N:5][CH:6]=[CH:7][CH:8]=2)[N:3]([C:10]2[CH:15]=[CH:14][C:13]([CH2:16][C:17]([OH:19])=O)=[CH:12][CH:11]=2)[CH:2]=1.[C:20]([C:24]1[CH:25]=[C:26]([NH2:42])[N:27]([C:29]2[CH:34]=[CH:33][C:32]([CH2:35][N:36]3[CH2:41][CH2:40][O:39][CH2:38][CH2:37]3)=[CH:31][CH:30]=2)[N:28]=1)([CH3:23])([CH3:22])[CH3:21]>>[C:20]([C:24]1[CH:25]=[C:26]([NH:42][C:17](=[O:19])[CH2:16][C:13]2[CH:12]=[CH:11][C:10]([N:3]3[C:4]4=[N:5][CH:6]=[CH:7][CH:8]=[C:9]4[N:1]=[CH:2]3)=[CH:15][CH:14]=2)[N:27]([C:29]2[CH:30]=[CH:31][C:32]([CH2:35][N:36]3[CH2:37][CH2:38][O:39][CH2:40][CH2:41]3)=[CH:33][CH:34]=2)[N:28]=1)([CH3:23])([CH3:21])[CH3:22]Participants
3
Procedure
The title compound is prepared as described in Example 28 but using 2-(4-imidazo[4,5-b]pyridine-3-yl-phenyl)-acetic acid and 5-tert-butyl-2-(4-morpholin-4-ylmethyl-phenyl)-2H-pyrazol-3-ylamine. Title compound: ES-MS: 550.09 [M-H]+; RTT=2.69 min (HPLC System 3).
Workup
- customThe title compound is prepared
- customRTT=2.69 min (HPLC System 3)
Sources & evidence
- ORD record
- ord-31ba67fc02ad4d29ac52556a29e99adb
- Source dataset
- uspto-grants-2011_10
- Patent number
- US08030311B2
Reaction notes
Loading…